<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is some <z:hpo ids='HP_0001289'>confusion</z:hpo> regarding the indications for and methodology of the use of contrast material in cranial computed tomography </plain></SENT>
<SENT sid="1" pm="."><plain>Some authors recommend a nonenhanced scan in <z:hpo ids='HP_0000001'>all</z:hpo> cases, followed by an enhanced scan if indicated by the symptoms or the appearance of the unenhanced scan </plain></SENT>
<SENT sid="2" pm="."><plain>Others have questioned the value of the nonenhanced scan in patients with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The authors offer a protocol for the use of contrast material </plain></SENT>
<SENT sid="4" pm="."><plain>Possible <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> patients are scanned with contrast material alone; other patients are scanned either (a) without contrast material or (b) both with and without contrast material, depending upon the most likely clinical diagnosis </plain></SENT>
</text></document>